Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2014 Nov 15;21(3):454–459. doi: 10.1016/j.bbmt.2014.11.007

Table 3.

Survival after DLI and 2nd HCT

			DLI		2^nd HCT

Time from HCT to relapse	N	Survival ≥ 1 year post relapse N (%)	p-value^£	N	Survival ≥ 1 year post relapse N (%)	p-value^£
<6 months	90	12 (13)	<0.001	110	35 (32)	<0.001
6 months–2 years	81	28 (35)		167	92 (55)
2 – 3 years	14	7 (50)		37	23 (62)
≥ 3 years	17	10 (59)		55	32 (58)
Median (range)	7 (1–177)^*	13 (2–106)		12 (1–150)^†	14 (2–78)

^£

p-value reflects the time from HCT to relapse

^*

Median survival of all patients receiving DLI

^†

Median survival of all patients receiving 2nd HCT